Literature DB >> 19291032

Emulsification by the phase inversion temperature method: the role of self-bodying agents and the influence of oil polarity.

T Förster1, F Schambil, H Tesmann.   

Abstract

Synopsis Oil-in-water emulsions stabilized with nonionic emulsifiers change to water-in-oil emulsions as the temperature rises when the hydrophilic and lipophilic properties of the mixed emulsifier are just balanced. Preparation above the phase inversion temperature followed by rapid cooling yields emulsions that exhibit very fine droplet size and extreme long-term stability. Cosmetic emulsions were prepared by this phase inversion temperature (PIT) method using typical raw materials such as polar oils, e.g. decyl oleate, 2-octyl dodecanol or isopropyl myristate, and nonionic emulsifiers, e.g. ceteareth-12 or polyoxyethylene eicosyl/docosyl ether combined with cetostearyl alcohol as a co-emulsifier. The phase inversion temperature was measured as a function of the oil polarity and the concentration of mixed emulsifier. The relationship between phase inversion temperature, droplet size and emulsion stability was investigated. In addition, self-bodying agents such as cetostearyl alcohol or monoglycerides were added to these thin, fine disperse emulsions to adjust the consistency. The influence of these ingredients on phase inversion temperature, droplet size, yield value and emulsion stability was studied.

Entities:  

Year:  1990        PMID: 19291032     DOI: 10.1111/j.1467-2494.1990.tb00537.x

Source DB:  PubMed          Journal:  Int J Cosmet Sci        ISSN: 0142-5463            Impact factor:   2.970


  2 in total

1.  A novel phase inversion-based process for the preparation of lipid nanocarriers.

Authors:  Béatrice Heurtault; Patrick Saulnier; Brigitte Pech; Jacques-Emile Proust; Jean-Pierre Benoit
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

2.  Influence of lipid nanocapsules composition on their aptness to freeze-drying.

Authors:  Claire Dulieu; Didier Bazile
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.